Anti-PD-1 therapy reverses TIGIT+CD226+NK depletion in immunotherapy resistance of hepatocellular carcinoma through PVR/TIGIT pathway
- Resource Type
- Article
- Source
- In
International Immunopharmacology 30 March 2024 130 - Subject
- Language
- ISSN
- 1567-5769